Article metrics

Original research
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers

 

Online download statistics by month:

Online download statistics by month: May 2024 to October 2024

AbstractFullPdf
May 202410851090435
Jun 20241049981294
Jul 20243573601592
Aug 2024192187117
Sep 20242132202288
Oct 2024182182106
Total307830204832